The cardiac and haemostatic effects of dietary hempseed

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Rodriguez Leyva, Delfin ^a,b   Pierce, Grant N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Cardiovascular Research Division   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCIUM; CANNABIS; CARBOHYDRATE; CHOLESTEROL; COPPER; FRUCTOSE; GLUCOSE; IRON; ISOLEUCINE; LEUCINE; LIPID; LYSINE; MAGNESIUM; MALTOSE; MANGANESE; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHORUS; POLYUNSATURATED FATTY ACID; POTASSIUM; PROTEIN; SATURATED FATTY ACID; SELENIUM; SODIUM; THREONINE; TRYPTOPHAN; UNINDEXED DRUG; ZINC;

ASH; ATHEROSCLEROSIS; ENERGY; FIBER; FOOD; HEART DISEASE; HEMOSTASIS; HEMPSEED; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MOISTURE; NONHUMAN; REVIEW; THROMBOCYTE AGGREGATION;

ANIMALIA; CANNABIS; CANNABIS SATIVA;

EID: 77951086636     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-32     Document Type: Review

References (51)

1. History of cannabis and its preparations in saga, science, andsobriquet. Russo EB, Chem Biodivers 2007 4 1614 48 10.1002/cbdv.200790144 17712811 (Pubitemid 47381191)
2. An ancient Egyptian herbal. Manniche L, Third University of Texas Press Printing 1989
3. GC-MS analysis of the total9-THC content of both drug-and fiber-type cannabis seeds. Ross SA, Mehmedic Z, Murphy TP, Elsohly MA, J Anal Toxicol 2000 24 715 717 11110027 (Pubitemid 32171220)
4. Delta9-tetrahydrocannabinol content of commercially available hemp products. Holler JM, Bosy TZ, Dunkley CS, Levine B, Past MR, Jacobs A, J AnalToxicol 2008 32 428 32
5. Hemp and Marijuana: Myths & Realities. West DP, North AmericanIndustrial Hemp Council, INC 1998 http://www.votehemp.com/PDF/myths- facts.pdf April 8,2009
6. Hempseed as a nutritional resource: An overview. Callaway JC, Euphytica 2004 140 65 72 10.1007/s10681-004-4811-6 (Pubitemid 40473738)
7. Welcome to Finola®. February 26 2009. http://www.finola.com/ April16, 2009
8. Nitric oxide and pathogenic mechanisms involved inthedevelopment of vascular diseases. Napoli C, Ignarro LJ, Arch Pharm Res 2009 32 1103 8 10.1007/s12272-009-1801-1 19727602
9. Association Between dietaryarginine and C-reactive protein. Wells BJ, Mainous AG, Everett CJ, Nutrition 2005 21 125 30 10.1016/j.nut.2004.03.021 15723738 (Pubitemid 40255719)
10. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH, N Engl J Med 1997 336 973 9 10.1056/NEJM199704033361401 9077376 (Pubitemid 27152782)
11. Clinical nutrition: 4. Omega-3 fatty acids in cardiovascularcare. Holub BJ, CMAJ 2002 166 608 15 11898942 (Pubitemid 34251494)
12. Fats and other lipids. Ensminger AH, Konlande JE, Foods & nutrition encyclopedia CRC Press, Ensminger AH, Konlande JE, 1993 691
13. USDA National Nutrient Database for Standard Reference, Release 22. October 10 2009. http://www.nal.usda.gov/fnic/foodcomp/search/ February 18, 2010
14. Metabolism of deuterium-labeled linolenic, linoleic, oleic, stearic and palmitic acid in humansubjects. Emken EA, Adlof RO, Rakoff H, Rohwedder WK, Synthesis and application of isotopicallylabeledcompounds Amsterdam: Elsevier Science Publishers, Baillie TA, Jones JR, 1988 713 716
15. The importance of the omega-6/omega-3 fatty acid ratio incardiovascular disease and other chronic diseases. Simopoulos AP, Exp Biol Med (Maywood) 2008 233 674 88 10.3181/0711-MR-311 18408140
16. Gamma-linolenic acid inhibits inflammatory responses by regulating NF-kappaB and AP-1 activationin lipopolysaccharide-induced RAW 264.7 macrophages. Chang CS, Sun HL, Lii CK, Chen HW, Chen PY, Liu KL, Inflammation 2010 33 46 57 10.1007/s10753-009-9157-8 19842026
17. Comparison of stearidonic acid and alpha-linolenicacid on PGE2 production and COX-2 protein levels in MDA-MB-231 breast cancer cell cultures. Horia E, Watkins BA, J Nutr Biochem 2005 16 184 92 10.1016/j.jnutbio.2004.11.001 15741054 (Pubitemid 40312172)
18. Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total andlipoprotein lipid concentrations and haemostatic factors. Schwab US, Callaway JC, Erkkilä AT, Gynther J, Uusitupa MI, Järvinen T, Eur J Nutr 2006 45 470 7 10.1007/s00394-006-0621-z 17103080 (Pubitemid 46020598)
19. Efficacy of dietary hempseed oil in patients with atopic dermatitis. Callaway J, Schwab U, Harvima I, Halonen P, Mykkänen O, Hyvönen P, Järvinen T, J Dermatolog Treat 2005 16 87 94 10.1080/09546630510035832 16019622 (Pubitemid 40676907)
20. Dietary hempseed reduces platelet aggregation. Richard MN, Ganguly R, Steigerwald SN, Al-Khalifa A, Pierce GN, J Thromb Haemost 2007 5 424 5 10.1111/j.1538-7836.2007.02327.x 17155962 (Pubitemid 46139474)
21. Cholesterol-induced stimulation of platelet aggregation is prevented byahempseed-enriched diet. Prociuk MA, Edel AL, Richard MN, Gavel NT, Ander BP, Dupasquier CM, Pierce GN, Can J Physiol Pharmacol 2008 86 153 9 10.1139/Y08-011 18418423 (Pubitemid 351536445)
22. The effects of dietary hempseed on cardiac ischemia/reperfusioninjury in hypercholesterolemic rabbits. Prociuk M, Edel A, Gavel N, Deniset J, Ganguly R, Austria J, Ander B, Lukas A, Pierce G, Exp Clin Cardiol 2006 11 198 205 18651032 (Pubitemid 44540864)
23. Effect ofdietary hempseed intake on cardiac ischemia-reperfusion injury. Al-Khalifa A, Maddaford TG, Chahine MN, Austria JA, Edel AL, Richard MN, Ander BP, Gavel N, Kopilas M, Ganguly R, Ganguly PK, Pierce GN, Am J Physiol RegulIntegr Comp Physiol 2007 292 1198 203
24. A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. Kaul N, Kreml R, Austria JA, Richard MN, Edel AL, Dibrov E, Hirono S, Zettler ME, Pierce GN, J Am Coll Nutr 2008 27 51 8 18460481 (Pubitemid 351600522)
25. Cholesterol and coronary heartdisease: predicting risks in men by changes in levels and ratios. Kinosian B, Glick H, Preiss L, Puder KL, J Investig Med 1995 43 443 450 8528755
26. Lack of effect of linoleic acid on thehigh-density-lipoprotein- cholesterol fraction of plasma lipoproteins. Iacono JM, Dougherty RM, Am J Clin Nutr 1991 53 660 4 1900384 (Pubitemid 21917638)
27. Hydrogenation alternatives: effects of trans fattyacids and stearic acid versus linoleic acid on serum lipids and lipoproteins inhumans. Zock PL, Katan MB, J Lipid Res 1992 33 399 410 1569387
28. Effects of dietaryfatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serumlipids andapolipoproteins: a meta-analysis of 60 controlled trials. Mensink RP, Zock PL, Kester AD, Katan MB, et al. Am J Clin Nutr 2003 77 1146 55 12716665 (Pubitemid 44858429)
29. GISSI-Prevenzione Investigators. Assessment of absolute risk of death after myocardial infarction by use ofmultiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Marchioli R, Avanzini F, Barzi F, Eur Heart J 2001 22 2085 103 10.1053/euhj.2000.2544 11686666 (Pubitemid 33091451)
30. Aprospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH, N Engl J Med 1991 325 373 381 10.1056/NEJM199108083250601 2062328
31. Relationship of dietary linoleic acid toblood pressure. The International Study of Macro-Micronutrients and BloodPressure. Miura K, Stamler J, Nakagawa H, International Study ofMacro-Micronutrients and Blood Pressure Research Group, Hypertension 2008 52 408 14 10.1161/HYPERTENSIONAHA.108.112383 18606902
32. Influenceofdietary linoleic acid on leucocyte sodium transport and blood pressure. Heagerty AM, Ollerenshaw JD, Robertson DI, Bing RF, Swales JD, BMJ 1986 293 295 297 10.1136/bmj.293.6542.295 3089491 (Pubitemid 16070825)
33. Effect oflinoleic and oleic acids on blood pressure, blood viscosity, anderythrocyte cationtransport. Sacks FM, Stampfer MJ, Monoz A, McManus K, Canessa M, Kass EH, J Am Coll Cardiol 1987 6 179 185
34. Blood pressure, dietary fats, and antioxidants. Salonen JT, Salonen R, Ihanainen M, Parviainen M, Seppänen R, Kantola M, Seppänen K, Rauramaa R, Am J Clin Nutr 1988 48 1226 1232 3189209
35. Atherosclerosis: an intracellulardeficiency in essential fatty acids. Cornwell DG, Panganamala RV, Prog Lipid Res 1981 20 365 76 10.1016/0163-7827(81) 90069-2 7043479
36. A defect in the activity of Delta6 and Delta5 desaturases may bea factor in the initiation and progression of atherosclerosis. Das UN, Prostaglandins LeukotEssent Fatty Acids 2007 76 251 68 10.1016/j.plefa.2007.03.001 (Pubitemid 46803265)
37. The atherogenic effects of chlamydia aredependent on serum cholesterol and specific to Chlamydia pneumoniae. Hu H, Pierce GN, Zhong G, J Clin Invest 1999 103 747 53 10.1172/JCI4582 10074493 (Pubitemid 29122429)
38. Chlamydiapneumoniae stimulates proliferation of vascular smooth muscle cells throughinduction of endogenous heat shock protein 60. Hirono S, Dibrov E, Hurtado C, Kostenuk A, Ducas R, Pierce GN, Circ Res 2003 93 710 6 10.1161/01.RES.0000095720.46043.F2 14500333 (Pubitemid 37288665)
39. Conversion ofalpha-linolenic acid in humans is influenced by the absolute amounts ofalpha-linolenicacid and linoleic acid in the diet and not by their ratio. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP, Am J Clin Nutr 2006 84 44 53 16825680 (Pubitemid 44699170)
40. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response tomarkedchanges in their dietary intake in men. Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ, J Lipid Res 2005 46 269 280 10.1194/jlr.M400225-JLR200 15576848 (Pubitemid 40271091)
41. Polyunsaturated fatty acids, inflammation, andcardiovascular disease: time to widen our view of the mechanisms. Sacks FM, Campos H, J Clin Endocrinol Metab 2006 91 398 400 10.1210/jc.2005-2459 16461954 (Pubitemid 43236900)
42. The role of dietary n-6 fatty acids in the prevention ofcardiovascular disease. Willett WC, J Cardiovasc Med (Hagerstown) 2007 8 Suppl 1 42 5 10.2459/01.JCM.0000289275.72556.13 17876199 (Pubitemid 47429082)
43. The effects of dietary flaxseed on vascular contractile function andatherosclerosis in rabbits during prolonged hypercholesterolemia. Dupasquier CMC, Weber AM, Ander BP, Rampersad PP, Steigerwald S, Wigle JT, Mitchell RW, Kroeger EA, Gilchrist JSC, Moghadasian MM, Lukas A, Pierce GN, Am J Physiol 2006 291 2987 H2996
44. Dietary flaxseed inhibitsatherosclerosis in the LDL receptor deficient mouse in part through anti-proliferative andanti-inflammatory actions. Dupasquier CMC, Dibrov E, Kneesh AL, Cheung PKM, Lee KGY, Alexander HK, Yeganeh B, Moghadasian MH, Pierce GN, Am J Physiol 2007 293 2394 2402
45. Tissue n-3 and n-6 fatty acids andrisk for coronary heart disease events. Harris WS, Poston WC, Haddock CK, Atherosclerosis 2007 193 1 10 10.1016/j.atherosclerosis.2007.03.018 17507020 (Pubitemid 46776717)
46. The Oslo diet-heart study. Eleven-year report. Leren P, Circulation 1970 42 935 942 5477261
47. Dietary prevention ofcoronaryheart disease: the Finnish mental hospital study. Turpeinen O, Karvonen MJ, Pekkarinen M, et al. Int J Epidemiol 1979 8 99 118 10.1093/ije/8.2.99 393644 (Pubitemid 10239890)
48. Controlled trial of soya-bean oil inmyocardialinfarction. Medical Research Council, Lancet 1968 2 693 699 4175085
49. Test of effect of lipid lowering by diet on cardiovascular risk. TheMinnesotacoronary survey. Frantz ID, Dawson EA, Ashman PL, Gatewood LC, Bartsch GE, Kuba K, Brewer ER, Arteriosclerosis 1989 9 129 135 2643423 (Pubitemid 19046099)
50. Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject. Patenaude A, Rodriguez-Leyva D, Edel AL, Dibrov E, Dupasquier CM, Austria JA, Richard MN, Chahine MN, Malcolmson LJ, Pierce GN, Eur J Clin Nutr 2009 63 1123 9 10.1038/ejcn.2009.41 19584895
51. Bioavailability of alpha-linolenic acid in subjects afteringestion of three different forms of flaxseed. Austria JA, Richard MN, Chahine MN, Edel AL, Malcolmson LJ, Dupasquier CM, Pierce GN, J Am Coll Nutr 2008 27 214 21 18689552